HUTCHMED Initiates Phase Ib/II Study of HMPL-453 in Combination with Chemotherapy or Toripalimab for Advanced Solid Tumors in China
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Feb. 04, 2022 (GLOBE NEWSWIRE) —…
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Feb. 04, 2022 (GLOBE NEWSWIRE) —…
Vancouver, British Columbia–(Newsfile Corp. – February 4, 2022) – Abner Labs announces the appointment of…
Improved Conditions and Execution Drive Strong Finish to 2021 and Favorable 2022 Outlook BROOKLYN HEIGHTS,…
Reports Fourth Quarter Revenues of $12.0 Billion; Full-Year Revenues of $46.4 Billion Posts Fourth Quarter…
Net Sales Increased 2.9% and Organic Net Sales Increased 1.6% Income from Continuing Operations Decreased…
Fourth Quarter Earnings Per Share of $1.37 and Record Fourth Quarter Adjusted Earnings Per Share…
NEW YORK & LONDON & MUMBAI, India–(BUSINESS WIRE)–#BPM–WNS (Holdings) Limited (NYSE: WNS), a leading provider…
This New Combined Business Is Intended to Be Separated From Spectrum Brands, Creating a New…
Results to impact ColoAlert profile for FDA submission Provides opportunity for ColoAlert to achieve gold…
GAITHERSBURG, Md., Feb. 04, 2022 (GLOBE NEWSWIRE) — Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company…
Strong 2021 sales and business EPS(1) growth enabling increased investment in R&D Paris, February 4,…
Strong 2021 sales and business EPS(1) growth enabling increased investment in R&D Paris, February 4,…
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus…
Dose selection complete for planned Phase 3 trial, expected to be initiated in 3Q2022 Sub-analysis…
NEW YORK–(BUSINESS WIRE)–Silver Spike Investment Corp. (“SSIC”), a newly-organized closed-end management investment company that has…
Toronto, Ontario–(Newsfile Corp. – February 3, 2022) – CardioComm Solutions, Inc. (TSXV: EKG) (“CardioComm” or…
NEW YORK–(BUSINESS WIRE)–theMaven, Inc. (OTCQX: MVEN), currently operating under the brand name The Arena Group…
First-ever lentiviral hematopoietic stem cell gene therapy approved for reimbursement by NHS England Two children…
BOSTON, Feb. 03, 2022 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology…
— Female-Led Company Strives to Transform Standard of Care in Secondary Prevention of Heart Attack or…